The global narcolepsy market is expected to reach US$ 4,537.9 Mn in 2027 from US$ 2,026.8 Mn in 2018. The market is estimated to grow with a CAGR of 9.5% from 2019-2027.
The growth of the narcolepsy market is primarily attributed to the rising prevalence of sleep related neurological disorders, emerging local pharmaceutical and biopharmaceutical companies, and increasing awareness regarding neurological disorders. However, side effects and risks associated with the narcolepsy medications and delayed diagnosis and misdiagnosis of the disease are likely to pose a negative impact on the market growth. On the other hand, robust pipeline of drugs intended for the treatment of narcolepsy is likely to have a positive impact on the growth of the global narcolepsy market in the coming years. The range of sleep disorders that are treated by neurologists is wide and includes conditions such as insomnia, sleep apnea, restless legs syndrome, and narcolepsy. These disorders cause disruptions in the normal sleep-wake mechanisms causing endogenous abnormalities. Neurological sleep related disorders is an emerging problem as the population is ageing at a rapid rate. According to the National Institute of Health (NIH), approximately 40 million Americans suffer from neurological diseases in the US, whereas additional 20 million people experience occasional sleeping problems. Sleep attacks are not limited to periods of dull or low engagement activities, but can happen during school or work hours, in the middle of a conversation, while eating, while exercising or playing sports, or even while driving. The increasing prevalence of neurological sleep disorders and narcolepsy is likely to foster the growth of market in the coming years.
- Table of Contents
- List of Tables & Figures
- Charts
- Research Methodology
Get FREE PDF Sample of Narcolepsy Market Report
In 2018, the narcolepsy with cataplexy segment held a largest market share of 65.1% of the narcolepsy market, by type. This segment is also expected to dominate the market in 2027 owing to its significant prevalence among patients suffering with narcolepsy. Episodes of cataplexy are reported to be encountered among 55-60% of patients suffering with narcolepsy. Moreover, the similar segment is anticipated to also witness the fastest growth rate of 9.7% during the forecast period, 2019 to 2027 owing to the increasing demand for drugs to treat the disease.
Global narcolepsy market, based on product was segmented into sodium oxybate, CNS stimulants and antidepressants. Sodium oxybate segment is anticipated to grow at a CAGR of 9.8% during the forecast period. Sodium oxybate is the one of the primary medication recommended by specialists to patients suffering with narcolepsy. The high cost of the branded counterparts, availability of reimbursement with certain regions as well as approval of the drug in majority of the top markets is likely to contribute to the growth and dominance of the segment. Sodium is oxybate is also expected to exhibit highest growth witnessing a robust CAGR over the forecast years.
Some of the major primary and secondary sources for narcolepsy included in the report are World Health Organization (WHO), European Medical Agency (EMA), National Health Commission (NHC), China National Drug Administration (CNDA), Food & Drug Administration (FDA), National Institute of Neurological Disorders and Strokes, International Federation of Pharmaceutical Manufacturers & Associations and others.
- What is the growth perspective of the Narcolepsy Market and the key dynamics and trends governing the market?
- What are key sustainability strategies adopted by the leading players in the Narcolepsy Market?
- What are the new and emerging technologies and use cases disrupting the Narcolepsy industry?
- What are the key applications where Narcolepsy plays a significant role?
CONTACT US:
276 5th Avenue, New York , NY 10001,United States
International: (+1) 646 781 7170
Email: [email protected]
Follow Us On linkedin :- https://www.linkedin.com/company/24-market-reports
North America Dental Equipment Market Research Report By Product (Dental Radiology Equipment, Dental Hand Pieces, CAD/CAM), By Application (Examining The Mouth & Teeth, Cavity Removal, Condensing Filling Materials), By End User – Forecast to 2027Overview:Technological innovation and implementation have scored well for dental industry and North America acts as the core for such research & developments.
The report includes drivers such as the prevalence of dental diseases, increasing geriatric population, infrastructural superiority, the launch of new dental procedures, rising healthcare expenditure, and government initiatives are helping the North America dental equipment market in moving ahead.On the flip side, the North America dental equipment market can get bogged down by poor reimbursement policies.Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/4625 Segmentation:The North American dental equipment market can be segmented by products, applications and end-user.Product-wise, the North American dental equipment market is segmented into dental radiology equipment, dental sensor, dental hand pieces, CAD/CAM, dental chairs, dental lasers, casting machines, and others.
The segment holds the largest market share of 32.6% and its valuation expects to reach USD 1,577.7 million by 2023.
The CAD/CAM consists software and equipment.
Regional Analysis:The North American dental equipment market has the U.S. in forefront where people have invested substantially in the healthcare sector and gaining much from it.
The budget for health care in the U.S. holds 16% of the total GDP which can be taken as a signifier for the increasing sale of the dental equipment market.
Global Blue Biotechnology Market To Project Significant Expansion At A CAGR of 10.2% During 2017-2023Market Synopsis:Blue biotechnology deals with the application of biotechnology to marine or aquatic sources at a molecular level to extract active new ingredients for development of new drugs and other purposes.
Market Research Future (MRFR) has published a report asserting that the global blue biotechnology market is anticipated to expand at a strong CAGR of 10.2% during the forecast period of 2017-2023.Request Sample Copy:https://www.marketresearchfuture.com/sample_request/713Market Driver and Restraints:Oceans and Seas consist of large biodiversity and the development in the field of biotechnology has made it possible to utilize the marine and aquatic sources for obtaining various products that are useful for mankind.
The availability of large market for blue biotech products in the various sectors is majorly driving the global blue biotechnology market.The increasing demand for blue biotech products in the pharmaceutical industry for production of various medicines and drugs is fueling the expansion of the global blue biotechnology market.
The flexibility, adaptivity and constant development of blue biotechnology are widening its application range in various industries.Market Segmentation:The global blue biotechnology market has been segmented on the basis of product, application and end-users.
Based on end-users, the blue biotechnology market is segmented into hospitals, pharmaceutical companies, biotechnology companies, research institutes, laboratories, and others.
Lack of awareness and less technological penetration in the underdeveloped area is resulting in the slow growth of blue biotechnology market in the Middle East and Africa region.Competitive Analysis:The rapidly increasing research and development expenditure by the players for innovative product launch in medical, cosmetics, food and other industries is triggering competition in the global blue biotechnology market.
The condition is characterized by excessive sleepiness, hallucination, sleep paralysis, excessive day time sleepiness, cataplexy, and automatic behaviors.
Narcolepsy is caused due to lack of brain chemical known as orexin which regulates sleep.
Increase in awareness about sleep disorders, rise in prevalence of these disorders due to unhealthy lifestyle, and surge in stress levels are the major factors anticipated to drive the global narcolepsy treatment market during the forecast period.
Increase in demand for advanced therapies for sleeping disorders, extensive efforts of government and non-governmental organizations for spreading awareness about the disease, rise in R activities to find a cure for narcolepsy are the other factors expected to propel the global market.
However, lack of awareness among patients and health care providers about the disease in developing countries are likely to restrain the global narcolepsy market during the forecast period.Request COVID Analysis on Narcolepsy Market –https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19_id=39383The global narcolepsy treatment market can be segmented based on drug class, narcolepsy type, end-user, and region.
In terms of drug class, the market can be classified into vasopressors, CNS stimulants, decongestants, serotonin reuptake inhibitors, and miscellaneous.
